Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
uveitis
Biotech
Alumis downsizes IPO, tacks on private placement
In the latest sign that biotech’s return to the public markets remains somewhat lackluster, Alumis has downsized its IPO.
James Waldron
Jun 28, 2024 5:02am
Alumis eyes $300M IPO to fund clinical-stage TYK2 pipeline
Jun 24, 2024 8:14am
Alumis plans IPO to fund TYK2 inhibitor through phase 3 trials
Jun 10, 2024 8:35am
Roivant ends longshot lupus program after phase 2 fail
Nov 27, 2023 9:48am
Acelyrin eyes IPO boost to $400M haul to take on Lilly, Novartis
Apr 14, 2023 6:10am
